Carlos Rodriguez Correa, MD
Cardiovascular Disease · Salt Lake City, UTNPI 1255858619
Payments from drug & device makers
Across 21 payments — averaging $117.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$1K
- Heartflow, Inc.$411
- Inari Medical, Inc.$191
- Amgen$118
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$117
- AstraZeneca$100
- plus $158 from 4 others
What the payments were for
- Travel & lodging$1,26551%
- Food & beverage$1,19949%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 4 | $1,369 |
| Heartflow, Inc. | 6 | $411 |
| Inari Medical, Inc. | 2 | $191 |
| Amgen | 1 | $118 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $117 |
| AstraZeneca | 1 | $100 |
| Edwards Lifesciences | 1 | $75 |
| Lantheus Medical Imaging, Inc. | 2 | $54 |
| Boston Scientific | 1 | $15 |
| E.r. Squibb & Sons, L.L.C. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AMPLATZER$655
- NAVITOR$601
- FFRct$383
- FLOWTRIEVER CATHETER, S$173
- CT THROMBECTOMY SYSTEM KIT$173
- Repatha$118
- MitraClip$104
- FARXIGA$100
How this compares
$2,463 in reported general payments places this provider in the 50th percentile of 131 cardiovascular disease providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 11 | $10,451 |
| Metoprolol Succinate | 33 | $327 |
| Potassium Chloride | 12 | $212 |
| Atorvastatin Calcium | 15 | $77 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Salt Lake City
- John RyanSalt Lake City$4.2M
- Jeffrey AndersonSalt Lake City$1.7M
- Robert FowlesSalt Lake City$611K
- Benjamin PetersonSalt Lake City$179K
- James FangSalt Lake City$161K
- Edward GilbertSalt Lake City$99K
- Lowell ChangSalt Lake City$96K
- Jeffrey OsbornSalt Lake City$92K
- Hannah RaaschSalt Lake City$62K
- Richard MeredithSalt Lake City$59K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.